Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research

Summary

The goal of this clinical trial is to evaluate the safety and efficacy of privosegtor, a neuroprotective candidate, in patients diagnosed with optic neuritis (ON). Researchers will compare privosegtor and the standard of care (methylprednisolone) to a placebo and standard of care (methylprednisolone).

Timeline

Start

2026-05-28

Primary completion

2027-12

Completion

2028-12

Drugs

Indications